Abstract
The introduction of highly active antiretroviral therapy (HAART) has been shown to decrease mortality rates and human immunodeficiency virus (HIV)-associated morbidity. In this review of resource utilization among HIV-infected persons over a 5-year period, we report decreased utilization of hospital services associated with decreased morbidity. Our analyses show that this trend in decreased hospital costs correlates with increased utilization of HAART. During the same period, a corresponding increase in outpatient and pharmacy costs is reported, again reflecting administration of HAART in the outpatient setting. We believe these results have important consequences for planning of health care utilization for those who provide care for HIV-infected persons. The use of HAART in our clinic has resulted in better clinical and economic outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
